Business Context and Reporting Period
Company: BioLife Solutions, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 2, 2026
Event: Regulation FD Disclosure regarding the issuance of an investor presentation dated March 2, 2026.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the release of an investor presentation (Exhibit 99.1) and does not contain audited or unaudited financial statements within the body of the document.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The document references an investor presentation available on the company website, but the specific content of that presentation is not included in the text of this 8-K.
Guidance, Outlook, and Risks
Management Commentary: The Company issued an investor presentation on March 2, 2026.
Legal Disclaimer: The information contained in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" under the Securities Exchange Act of 1934. It is not subject to the liabilities of Section 18 of the Exchange Act and will not be incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are disclosed in this filing text.
Investor Verification Checklist
- Review the full text of the Investor Presentation (Exhibit 99.1) available at the provided URL for detailed financial data and strategic outlook.
- Verify that the presentation is not considered "filed" information for liability purposes under Section 18 of the Exchange Act.
- Confirm the date of the presentation (March 2, 2026) aligns with the most recent market expectations.